LPL Financial’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,000
Closed -$4K 3524
2019
Q4
$4K Hold
10,000
﹤0.01% 3341
2019
Q3
$6K Hold
10,000
﹤0.01% 3282
2019
Q2
$8K Hold
10,000
﹤0.01% 3267
2019
Q1
$10K Hold
10,000
﹤0.01% 3172
2018
Q4
$8K Hold
10,000
﹤0.01% 3056
2018
Q3
$28K Hold
10,000
﹤0.01% 3190
2018
Q2
$28K Hold
10,000
﹤0.01% 3167
2018
Q1
$20K Hold
10,000
﹤0.01% 3150
2017
Q4
$23K Hold
10,000
﹤0.01% 2998
2017
Q3
$21K Hold
10,000
﹤0.01% 2841
2017
Q2
$22K Hold
10,000
﹤0.01% 2771
2017
Q1
$27K Hold
10,000
﹤0.01% 2671
2016
Q4
$28K Hold
10,000
﹤0.01% 2656
2016
Q3
$30K Buy
+10,000
New +$37.6K ﹤0.01% 2596

Other funds holding SPHS

LPL Financial's SPHS Position: Q1 2020 in Review

LPL Financial sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 10,000 shares — an estimated $4K sold.

LPL Financial first reported a position in SPHS in Q3 2016 and held it in 14 quarters. The position peaked at $30K in Q3 2016. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • LPL Financial reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • LPL Financial sold 10,000 Sophiris Bio, Inc. shares in Q1 2020, an estimated $4K.
  • LPL Financial first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 14 quarters.
  • LPL Financial's Sophiris Bio, Inc. position peaked at $30K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.